Rare Liver Diseases Month shines spotlight on transitions in care
Rare Liver Diseases Month, observed every February, seeks to call attention to the more than 100 rare liver disorders that affect a significant portion…
Liver disease
Ocera Starts Second Part of Trial of OCR-002 for Liver Disease That Impacts Mental Functioning
Ocera Therapeutics has started the second part of a Phase 1/2a clinical trial of OCR-002 (ornithine phenylacetate) tablets as a treatment for a liver…
Australian Researchers Investigate Zinc as Potential Ally Against Liver Disease
A study by Australia’s Westmead Institute has revealed an unexpected role for zinc in liver disease. Researchers at the institute’s Storr Liver Center showed that…
Recent Posts
- Potential biliary atresia treatment AX-0810 to enter clinical testing
- Autoimmune hepatitis therapy hits FDA roadblock, future uncertain
- Seladelpar approved in Canada as Lyvdelzi to treat adults with PBC
- Finding hope for the future of transplants in a pig liver
- Itching was main sign of teen’s liver disease: Case report